Ambler, PA, United States of America

Daniel F Veber


Average Co-Inventor Count = 2.6

ph-index = 20

Forward Citations = 1,488(Granted Patents)


Inventors with similar research interests:


Company Filing History:


Years Active: 1976-2009

Loading Chart...
79 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Daniel F. Veber and His Contributions to Protease Inhibitors

Introduction: Daniel F. Veber, based in Ambler, Pennsylvania, is an influential inventor with a remarkable portfolio of 79 patents. His innovative work primarily focuses on the development of protease inhibitors, which play a crucial role in treating various diseases associated with bone and cartilage degradation.

Latest Patents: Among his latest patents, Veber has made significant advancements in the formulation of Calkyl-4-amino-azepan-3-one protease inhibitors. These compounds are designed to inhibit proteases, most notably cathepsin K, and are used to create pharmaceutical compositions for treating conditions such as osteoporosis, gingivitis, periodontitis, arthritis (including osteoarthritis and rheumatoid arthritis), Paget's disease, hypercalcemia of malignancy, metabolic bone disease, and even parasitic diseases like malaria. Another noteworthy patent features 4-amino-azepan-3-one protease inhibitors with similar applications, emphasizing their impact in the medical field.

Career Highlights: Daniel F. Veber has established a prominent career within the pharmaceutical industry, working with renowned companies such as Merck & Company, Inc. and SmithKline Beecham Corporation. His expertise and innovation have significantly contributed to the field of pharmacology, particularly in the area of protease inhibitors.

Collaborations: Throughout his career, Veber has collaborated with esteemed colleagues, including Ruth F. Nutt and Roger M. Freidinger. These partnerships have enabled him to enhance his research and development efforts, further solidifying his reputation as a leader in his field.

Conclusion: Daniel F. Veber's contributions to the realm of protease inhibitors showcase his dedication to improving human health through innovative medicinal chemistry. His extensive patent portfolio reflects his commitment to developing treatments for complex medical conditions, making him a standout figure in the world of inventions and innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…